Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo Dienstmann

Showing results (111-120 of 176) with videos related to

Pageof 18
Sort By:
Radiology. Artificial Intelligence|April 24, 2024
Erratum for: Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in CancerOlivia Prior, Carlos Macarro, Víctor Navarro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2015
Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal CancerOriol Arqués, Irene Chicote, Isabel Puig, et al.
Journal of Internal Medicine|August 29, 2023
Precision cancer medicine: Concepts, current practice, and future developmentsAnders Edsjö, Louise Holmquist, Birgit Geoerger, et al.
Radiology. Artificial Intelligence|January 31, 2024
Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in CancerOlivia Prior, Carlos Macarro, Víctor Navarro, et al.
NPJ Precision Oncology|November 21, 2025
Determinants of long-term response to patritumab deruxtecan in breast cancer patient-derived xenograftsAndreu Òdena, Laia Monserrat, Fara Brasó-Maristany, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid TumorsJosep Tabernero, Rastislav Bahleda, Rodrigo Dienstmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2015
Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithelial TumorsDejan Juric, Rodrigo Dienstmann, Andres Cervantes, et al.
Molecular Oncology|June 16, 2017
Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insightsRodrigo Dienstmann, Elena Elez, Guillem Argiles, et al.
Frontiers in Oncology|July 2, 2024
The somatic mutation profile of estrogen receptor-positive HER2-negative metastatic breast cancer in Brazilian patientsTomás Reinert, Fernanda Orpinelli do Rego, Matheus Costa E Silva, et al.
European Journal of Cancer (Oxford, England : 1990)|May 29, 2026
Quality and safety of research biopsies in oncology clinical trialsPaolo Nuciforo, Fiorella Ruiz-Pace, José Jimenez, et al.
Pageof 18

Showing results (111-120 of 176) with videos related to

Sort By:
Pageof 18
Radiology. Artificial Intelligence|April 24, 2024
Erratum for: Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in CancerOlivia Prior, Carlos Macarro, Víctor Navarro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2015
Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal CancerOriol Arqués, Irene Chicote, Isabel Puig, et al.
Journal of Internal Medicine|August 29, 2023
Precision cancer medicine: Concepts, current practice, and future developmentsAnders Edsjö, Louise Holmquist, Birgit Geoerger, et al.
Radiology. Artificial Intelligence|January 31, 2024
Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in CancerOlivia Prior, Carlos Macarro, Víctor Navarro, et al.
NPJ Precision Oncology|November 21, 2025
Determinants of long-term response to patritumab deruxtecan in breast cancer patient-derived xenograftsAndreu Òdena, Laia Monserrat, Fara Brasó-Maristany, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2015
Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid TumorsJosep Tabernero, Rastislav Bahleda, Rodrigo Dienstmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2015
Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithelial TumorsDejan Juric, Rodrigo Dienstmann, Andres Cervantes, et al.
Molecular Oncology|June 16, 2017
Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insightsRodrigo Dienstmann, Elena Elez, Guillem Argiles, et al.
Frontiers in Oncology|July 2, 2024
The somatic mutation profile of estrogen receptor-positive HER2-negative metastatic breast cancer in Brazilian patientsTomás Reinert, Fernanda Orpinelli do Rego, Matheus Costa E Silva, et al.
European Journal of Cancer (Oxford, England : 1990)|May 29, 2026
Quality and safety of research biopsies in oncology clinical trialsPaolo Nuciforo, Fiorella Ruiz-Pace, José Jimenez, et al.
Pageof 18